Wo

WOMEN ATTENDED FOR ASSESSMENT TOTAL
WOMEN DEFINITELY MICRO-INVASIVE TOTAL
WOMEN INVASIVE STATUS NOT KNOWN TOTAL
WOMEN INVITED FOR ROUTINE SCREENING WITH TECHNICALLY ADEQUATE RESULT (PERCENTAGE OF INVITED)
WOMEN INVITED FOR SCREENING IN LAST THREE YEARS TOTAL (CALL AND RECALL)
WOMEN INVITED FOR SCREENING IN PERIOD TOTAL
WOMEN INVITED FOR SCREENING IN PERIOD TOTAL (CALL AND RECALL)
WOMEN INVITED TOTAL (OPEN BREAST SCREENING EPISODE)
WOMEN LOST TO FOLLOW-UP TOTAL (AFTER TECHNICALLY INADEQUATE SCREENING MAMMOGRAM)
WOMEN LYMPH NODES PATHOLOGY RESULT NEGATIVE TOTAL
WOMEN LYMPH NODES PATHOLOGY RESULT POSITIVE TOTAL
WOMEN LYMPH NODES PATHOLOGY RESULT UNKNOWN TOTAL
WOMEN NEVER SCREENED TOTAL (NOT SELECTED FOR SCREENING)
WOMEN NEVER SCREENED TOTAL (SELECTED FOR SCREENING)
WOMEN NON-INVASIVE OR POSSIBLY MICRO-INVASIVE TOTAL
WOMEN NOT INVITED TOTAL (OPEN BREAST SCREENING EPISODE)
WOMEN RECALL CEASED TOTAL (UPPER TIER LOCAL AUTHORITY)
WOMEN SCREENED IN LAST THREE YEARS TOTAL
WOMEN SCREENED IN LAST THREE YEARS TOTAL (CALL AND RECALL)
WOMEN SCREENED IN LAST THREE YEARS TOTAL (SELF AND GP REFERRALS)
WOMEN SCREENED IN PERIOD TOTAL
WOMEN SCREENED IN PERIOD TOTAL (CALL AND RECALL)
WOMEN SCREENED IN PERIOD TOTAL (SELF AND GP REFERRALS)
WOMEN SCREENED TOTAL (HIGH RISK EPISODE)
WOMEN SCREENED TOTAL (TECHNICALLY ADEQUATE)
WOMEN TOTAL (HIGH RISK EPISODE)
WOMEN WITH CANCER DIAGNOSED WITHOUT CYTOLOGY OR HISTOLOGY TOTAL
WOMEN WITH CANCER TOTAL
WOMEN WITH FIRST OFFERED APPOINTMENT WITHIN 36 MONTHS OF PREVIOUS SCREEN (PERCENTAGE)
ISO 9001 CERTIFICATION EUROPE